Life Sciences Perspective On Emerging U.S. Patent Reform Efforts

Though largely absent from mainstream news, proposed reforms to patent law are poised to affect everything from biotech startups to major pharmaceutical R&D programs.Specifically, there are four ongoingbipartisaneffortsto modernize the U.S. intellectual property (IP) systemthatcould reshape the future of biomedical innovation in the United States. Legislators from both sides of the aisle are working collaboratively.These updates could profoundly impact the life sciences industry, where strong patent protections are critical for translating research into lifesaving therapies and diagnostics.

Reinstating Effective Remedies for IP Theft in the Biotech Sector

The RESTORE Patent Rights Act, introduced February 25 of this year, seeks to reverse the consequences of the Supreme Court's 2006 eBay v.MercExchangedecision, which significantly limited the ability of patent holders to obtain injunctions against infringers.